- Home
- VIR vs MCBS Comparison
VIR vs MCBS Comparison
Compare VIR & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIR
- MCBS
- Stock Information
- Founded
- VIR 2016
- MCBS 2006
- Country
- VIR United States
- MCBS United States
- Employees
- VIR N/A
- MCBS N/A
- Industry
- VIR Biotechnology: Pharmaceutical Preparations
- MCBS Major Banks
- Sector
- VIR Health Care
- MCBS Finance
- Exchange
- VIR Nasdaq
- MCBS Nasdaq
- Market Cap
- VIR 844.9M
- MCBS 745.5M
- IPO Year
- VIR 2019
- MCBS 2019
- Fundamental
- Price
- VIR $5.13
- MCBS $28.69
- Analyst Decision
- VIR Strong Buy
- MCBS Hold
- Analyst Count
- VIR 7
- MCBS 1
- Target Price
- VIR $32.86
- MCBS $34.00
- AVG Volume (30 Days)
- VIR 1.1M
- MCBS 47.8K
- Earning Date
- VIR 07-31-2025
- MCBS 07-18-2025
- Dividend Yield
- VIR N/A
- MCBS 3.24%
- EPS Growth
- VIR N/A
- MCBS 30.91
- EPS
- VIR N/A
- MCBS 2.58
- Revenue
- VIR $20,861,000.00
- MCBS $143,775,000.00
- Revenue This Year
- VIR N/A
- MCBS $16.00
- Revenue Next Year
- VIR N/A
- MCBS $31.75
- P/E Ratio
- VIR N/A
- MCBS $11.01
- Revenue Growth
- VIR N/A
- MCBS 19.70
- 52 Week Low
- VIR $4.32
- MCBS $24.24
- 52 Week High
- VIR $14.45
- MCBS $36.15
- Technical
- Relative Strength Index (RSI)
- VIR 48.62
- MCBS 56.56
- Support Level
- VIR $5.00
- MCBS $27.73
- Resistance Level
- VIR $5.35
- MCBS $28.50
- Average True Range (ATR)
- VIR 0.24
- MCBS 0.50
- MACD
- VIR 0.02
- MCBS 0.09
- Stochastic Oscillator
- VIR 31.21
- MCBS 78.87
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
About MCBS MetroCity Bankshares Inc.
MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.